{'fraction_non_alphanumeric': 0.028481012658227847, 'fraction_numerical': 0.0031645569620253164, 'mean_word_length': 6.033333333333333, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Use of Recombinant Tissue‐Type Plasminogen Activator to Treat Massive Pulmonary Embolism after Cesarean Section: A Case Report

A 30‐year‐old primigravida, delivering by cesarean section, went into shock with cardiac arrest due to pulmonary thromboembolism. Thrombolytic therapy with recombinant‐tissue‐type plasminogen activator (rt‐PA) induced a rapid improvement in both the hemodynamic and respiratory conditions. This case shows the marked efficacy of rt‐PA in treating massive pulmonary thromboembolism. Close attension must be given to the patient in such a case, however, because the risk of hemorrhagic complication exists.